Css LLC Summit Therapeutics Inc. Call Options Transaction History

Css LLC

  • $999 Million
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$2.39 - $10.92 $4,780 - $21,840
2,000 New
2,000 $15,000
Q3 2023

Nov 14, 2023
SELL
$1.54 - $2.42 $3,080 - $4,840
-2,000 Reduced 80.0%
500 $0
Q2 2023

Aug 14, 2023
BUY
$1.32 - $2.81 $1,452 - $3,091
1,100 Added 78.57%
2,500 $6,000
Q1 2023

May 15, 2023
BUY
$1.38 - $5.41 $1,931 - $7,574
1,400 New
1,400 $2,000

Others Institutions Holding SMMT

# of Institutions
193
Shares Held
75.8M
Call Options Held
2.01M
Put Options Held
2.84M
View Full List

About Summit Therapeutics Inc.

SMMT Quotes by TradingView
  • Ticker SMMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,215,008
  • Market Cap $3.78B
  • Description
  • Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...
More about SMMT
Track This Portfolio

Track Css LLC Portfolio

Follow Css LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

News

Stay updated on Css LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email